Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery

Neuroscience

Volumn 155, Issue 1, 2008, Pages 250-257

  Espana R A ^a   Roberts, D C S ^a   Jones, S R ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

cocaine methiodide; fast scan cyclic voltammetry; nucleus accumbens; onset; rat

Indexed keywords

COCAINE; DOPAMINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTRIC STIMULATION; INJECTIONS, INTRAVENOUS; MALE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 47249090821     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.05.022     Document Type: Article

References (45)

1. Ahmed S.H., Lin D., Koob G.F., and Parsons L.H. Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem 86 (2003) 102-113
2. Andersen P.H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166 (1989) 493-504
3. Batsche K., Granoff M.I., and Wang R.Y. 5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat. Brain Res 592 (1992) 273-277
4. Baumann M.H., Char G.U., de Costa B.R., Rice K.C., and Rothman R.B. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271 (1994) 1216-1222
5. Budygin E.A., Kilpatrick M.R., Gainetdinov R.R., and Wightman R.M. Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry. Neurosci Lett 281 (2000) 9-12
6. Cahill P.S., Walker Q.D., Finnegan J.M., Mickelson G.E., Travis E.R., and Wightman R.M. Microelectrodes for the measurement of catecholamines in biological systems. Anal Chem 68 (1996) 3180-3186
7. Desai R.I., Kopajtic T.A., French D., Newman A.H., and Katz J.L. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. J Pharmacol Exp Ther 315 (2005) 397-404
8. Dickerson L.W., Rodak D.J., Kuhn F.E., Wahlstrom S.K., Tessel R.E., Visner M.S., Schaer G.L., and Gillis R.A. Cocaine-induced cardiovascular effects: lack of evidence for a central nervous system site of action based on hemodynamic studies with cocaine methiodide. J Cardiovasc Pharmacol 33 (1999) 36-42
9. Einhorn L.C., Johansen P.A., and White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J Neurosci 8 (1988) 100-112
10. Engberg G., Elverfors A., Jonason J., and Nissbrandt H. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity. Synapse 25 (1997) 215-226
11. Evans S.M., Cone E.J., and Henningfield J.E. Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279 (1996) 1345-1356
12. Fowler J.S., Volkow N.D., Logan J., Gatley S.J., Pappas N., King P., Ding Y.S., and Wang G.J. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations. Synapse 28 (1998) 111-116
13. Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., Macgregor R.R., Hitzemann R., Logan J., Bendriem B., and Gatley S.J. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4 (1989) 371-377
14. Greco P.G., and Garris P.A. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur J Pharmacol 479 (2003) 117-125
15. Heien M.L., Khan A.S., Ariansen J.L., Cheer J.F., Phillips P.E., Wassum K.M., and Wightman R.M. Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc Natl Acad Sci U S A 102 (2005) 10023-10028
16. Hemby S.E., Co C., Koves T.R., Smith J.E., and Dworkin S.I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology (Berl) 133 (1997) 7-16
17. Hemby S.E., Jones G.H., Hubert G.W., Neill D.B., and Justice J.B. Assessment of the relative contribution of peripheral and central components in cocaine place conditioning. Pharmacol Biochem Behav 47 (1994) 973-979
18. Hinerth M.A., Collins H.A., Baniecki M., Hanson R.N., and Waszczak B.L. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons. Synapse 38 (2000) 305-312
19. Howell L.L., and Byrd L.D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258 (1991) 178-185
20. Jones S.R., Garris P.A., Kilts C.D., and Wightman R.M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem 64 (1995) 2581-2589
21. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., and Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73 (1999) 2406-2414
22. Kiyatkin E.A., Kiyatkin D.E., and Rebec G.V. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience 98 (2000) 729-741
23. Kiyatkin E.A., and Rebec G.V. Dopamine-independent action of cocaine on striatal and accumbal neurons. Eur J Neurosci 12 (2000) 1789-1800
24. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
25. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14 (1991) 299-302
26. Mateo Y., Budygin E.A., Morgan D., Roberts D.C., and Jones S.R. Fast onset of dopamine uptake inhibition by intravenous cocaine. Eur J Neurosci 20 (2004) 2838-2842
27. Nakachi N., Kiuchi Y., Inagaki M., Inazu M., Yamazaki Y., and Oguchi K. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur J Pharmacol 281 (1995) 195-203
28. Nash J.F., and Brodkin J. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J Pharmacol Exp Ther 259 (1991) 820-825
29. Pettit H.O., and Justice J.B. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34 (1989) 899-904
30. Pitts D.K., and Marwah J. Cocaine modulation of central monoaminergic neurotransmission. Pharmacol Biochem Behav 26 (1987) 453-461
31. Quinn D.I., Wodak A., and Day R.O. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Clin Pharmacokinet 33 (1997) 344-400
32. Roberts D.C. Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology (Berl) 111 (1993) 202-206
33. Rothman R.B., Mele A., Reid A.A., Akunne H.C., Greig N., Thurkauf A., de Costa B.R., Rice K.C., and Pert A. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav 40 (1991) 387-397
34. Samaha A.N., Mallet N., Ferguson S.M., Gonon F., and Robinson T.E. The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J Neurosci 24 (2004) 6362-6370
35. Seecof R., and Tennant F.S. Subjective perceptions to the intravenous "rush" of heroin and cocaine in opioid addicts. Am J Drug Alcohol Abuse 12 (1986) 79-87
36. Shriver D.A., and Long J.P. A pharmacologic comparison of some quaternary derivatives of cocaine. Arch Int Pharmacodyn Ther 189 (1971) 198-208
37. Stafford D., Lesage M.G., Rice K.C., and Glowa J.R. A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62 (2001) 41-47
38. Tessel R.E., Smith C.B., Russ D.N., and Hough L.B. The effects of cocaine HC1 and a quaternary derivative of cocaine, cocaine methiodide, on isolated guinea-pig and rat atria. J Pharmacol Exp Ther 205 (1978) 568-576
39. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., and Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
40. Wakazono Y., and Kiyatkin E.A. Electrophysiological evaluation of the time-course of dopamine uptake inhibition induced by intravenous cocaine at a reinforcing dose. Neuroscience 151 (2008) 824-835
41. Wightman R.M., Heien M.L., Wassum K.M., Sombers L.A., Aragona B.J., Khan A.S., Ariansen J.L., Cheer J.F., Phillips P.E., and Carelli R.M. Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci 26 (2007) 2046-2054
42. Wise R.A., Newton P., Leeb K., Burnette B., Pocock D., and Justice J.B. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 120 (1995) 10-20
43. Wojnicki F.H.E., and Glowa J.R. Effects of drug history on the acquisition of responding maintained by GBR 12909 in rhesus monkeys. Psychopharmacology 123 (1996) 34-41
44. Wu Q., Reith M.E., Wightman R.M., Kawagoe K.T., and Garris P.A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 112 (2001) 119-133
45. Zernig G., Giacomuzzi S., Riemer Y., Wakonigg G., Sturm K., and Saria A. Intravenous drug injection habits: drug users' self-reports versus researchers' perception. Pharmacology 68 (2003) 49-56